L-Annamycin for Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for L-Annamycin for Injection, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML [Phase 2, Phase 3]